Skip to content

Evaluation of Ocular Comfort With ISTA Tears vs Systane

Evaluation of Ocular Comfort With ISTA Tears vs Systane

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01650584
Enrollment
35
Registered
2012-07-26
Start date
2012-06-30
Completion date
2013-01-31
Last updated
2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Disease

Brief summary

To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)

Interventions

DRUGISTA Tears

sterile ophthalmic solution

Sterile ophthalmic solution

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* OSDI \>12

Exclusion criteria

* Presence of any active ocular disease other than dry eye

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Preference for One of the Treatments30 daysThere were 35 participants who applied ISTA Tears to the right eye and Systane to the left eye (70 eyes total). Participants were asked to indicate which treatment they preferred, or if they preferred neither.

Countries

United States

Participant flow

Recruitment details

There were 35 participants who applied ISTA Tears to the right eye and Systane to the left eye (70 eyes total).

Participants by arm

ArmCount
All Participants Received Both ISTA Tears and Systane
ISTA Tears: sterile ophthalmic solution used in the right eye. Systane: Sterile ophthalmic solution used in the left eye.
35
All Participants Received Both ISTA Tears and Systane
ISTA Tears: sterile ophthalmic solution used in the right eye. Systane: Sterile ophthalmic solution used in the left eye.
70
Total105

Baseline characteristics

CharacteristicAll Participants Received Both ISTA Tears and Systane
Age, Customized
At least 18 years of age
35 Participants
Region of Enrollment
United States
35 Participants
Sex/Gender, Customized
Both male or female
35 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 35
other
Total, other adverse events
0 / 35
serious
Total, serious adverse events
0 / 35

Outcome results

Primary

Percentage of Participants With Preference for One of the Treatments

There were 35 participants who applied ISTA Tears to the right eye and Systane to the left eye (70 eyes total). Participants were asked to indicate which treatment they preferred, or if they preferred neither.

Time frame: 30 days

Population: There were 35 participants who applied ISTA Tears to the right eye and Systane to the left eye (70 eyes total).

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Overall ParticipantsPercentage of Participants With Preference for One of the TreatmentsISTA Tears preferred23 Participants
Overall ParticipantsPercentage of Participants With Preference for One of the TreatmentsNeither preferred1 Participants
Overall ParticipantsPercentage of Participants With Preference for One of the TreatmentsSystane preferred11 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026